"Białostockie Centrum Onkologii im. Marii Skłodowskiej-Curie w Białymstoku jest jedyną w województwie podlaskim wielospecjalistyczną placówką zajmującą się rozpoznawaniem i leczeniem chorób nowotworowych. Białostockie Centrum Onkologii ma długą historię z początkami przy Szpitalu Ginekologiczno-Położniczym. Od 1993 r. ma patrona - Marię Skłodowską-Curie."

During the past decade, Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 14 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Puma Biotechnology, Inc." with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Clovis Oncology, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej" #1 collaborator was "Biocompatibles UK Ltd" with 1 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej" are "Breast Cancer" (8 trials), "Ovarian Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Cervical Cancer" (2 trials) and "Colorectal Cancer Metastatic" (1 trials). Many other conditions were trialed in "Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej" in a lesser frequency.

Most popular intervention types in "Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej" are "Drug" (22 trials), "Device" (2 trials), "Other" (2 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (6 trials), "Paclitaxel" (6 trials), "Trastuzumab" (5 trials), "Placebo" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej" are 12 trials for "Female" genders and 11 trials for "All" genders.

Currently, there are NaN active trials in "Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej has several departments that took part in Clinical trials: "Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej" - 2 trials